The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
The Cybersecurity and Infrastructure Security Agency, National Security Agency and international agencies Sept. 3 released joint guidance outlining a “software…
Headline
Chinese state-sponsored cyber actors are maliciously targeting networks globally, including telecommunications, government and others, according to a joint…
Headline
The FBI Aug. 20 released an advisory warning of malicious activity by Russian cyber actors targeting end-of-life devices running an unpatched vulnerability in…
Headline
The Cybersecurity and Infrastructure Security Agency, Environmental Protection Agency, National Security Agency, FBI and international agencies Aug. 13…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
The Department of Justice Aug. 11 announced a series of actions taken against the BlackSuit ransomware group, also known as “Royal,” including the disruption…